After surgery for prostate cancer, Todd Elworthy’s PSA came back elevated. Radiation was advised as the next step and Elworthy looked into a Fred Hutch clinical trial and proton therapy. Though he ...
Jennifer Capasso had endured multiple tumors. She wondered what might be said during her next cancer surgery. So, she hit ...
It's one of the most common forms of cancer in men, yet too many do not know the crucial warning signs to look out for, a ...
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), a leader in the development of differentiated targeted radiotherapies, today announced compelling preclinical data for ATNM-400, a first-in-class ...
When Michael Swinn blew the whistle on a colleague whose work was endangering lives, he thought the evidence so strong that ...
What causes people with cancer to die?The answer, it turns out, may be much different than the medical community has long ...
Accord Healthcare today announced the launch of Osvyrti (denosumab), a biosimilar to Prolia® (Amgen), and Jubereq (denosumab), a biosimilar to Xgeva® (Amgen), following the scheduled expiry of the ...
Cancer cells behave differently from normal cells, and some tumours may even use autophagy to survive. That’s why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback